-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 12 | 5700.00 | 5710.50 | 15 |
| 150 | 5678.50 | 5715.00 | 1 |
| 1 | 5641.00 | 5730.00 | 4 |
| 1 | 5632.90 | 5750.00 | 4 |
| 20 | 5630.00 | 5751.00 | 1 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 12 | 5700.00 | 5710.50 | 15 |
| 150 | 5678.50 | 5715.00 | 1 |
| 1 | 5641.00 | 5730.00 | 4 |
| 1 | 5632.90 | 5750.00 | 4 |
| 20 | 5630.00 | 5751.00 | 1 |
| 0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
| Open | 5,704.50 |
| Previous Close | 5,700.00 |
| Volume | 110,129.00 |
| Value (Lacs) | 6,277.35 |
| VWAP | 5,685.27 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 68,152 |
| High | 5,732.00 |
| Low | 5,637.50 |
| UC Limit | 6,270.00 |
| LC Limit | 5,130.00 |
| 52 Week High | 5,868.00 |
| 52 Week Low | 4,491.65 |
| Face Value | 2.00 |
| All Time High | 6,439.90 |
| All Time Low | 1,152.50 |
| 20D Avg Volume | 171,064 |
| 20D Avg Delivery(%) | 58.05 |
| Book Value Per Share | 1,002.37 |
| Dividend Yield | 0.79 |
| TTM EPS See historical trend | 197.47 (+11.23% YoY) |
| TTM PE See historical trend | 28.87 (Low PE) |
| P/B See historical trend | 5.69 (Average P/B) |
| Sector PE | 39.94 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
7 out of 10 years Alkem Laboratories has given positive returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 26.91% (2023) | 6.97% | -2.37% (2024) | -1.28% | 4.50% |
Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal Nov 17 2025 01:06 PM
Reduce Alkem Labs; target of Rs 5850: Choice Institutional Equities Nov 17 2025 10:59 AM
Stocks to Watch Today: Glenmark Pharma, Alkem Labs, Syrma SGS, Vikran Engineering, Ather Energy, Jindal Stainless, Vodafone, Baazar Style in focus on 11 November Nov 11 2025 03:01 AM
Cough and cold medicine sales dip in October as syrup safety concerns mount Nov 10 2025 04:51 PM
The company and its its subsidiaries announced the launch of DSS, the original De Simone formulation probiotic blend in India for restoring gut microbiota balance and managing various gut-related health conditions. View more
Posted by : kamal20
Posted by : The Fixed Income
Repost this message
Your Investment Portfolio Deserves a Fixed Return for Balance 9.75% IIFL SAMASTA FINANCE LIMITED 16/Jul/2028 ✔️ Coupon: 9.75% ✔️ Rating: CRISIL AA- Stable ✔️ Tenor: 2y 7m (Maturity: 16/Jul/2028) Senior Secured Bond | NBFC Bonds | High Return Bond | Listed Strengthen your portfolio with a high-yield instrument that prioritises safety, stability, and predictable income. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJHbVp3PT0=/975-iifl-samasta-finance-limited-16jul2028?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
| Qty 641712 | Price 4680 | % Traded 0.55 |
| Qty 641712 | Price 4680 | % Traded 0.55 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 755400 | Price 4831.92 | % Traded 0.62 |
| Qty 1700000 | Price 4874.61 | % Traded 1.42 |
| Qty 641712 | Price 4680 | % Traded 0.55 |
| Qty 989506 | Price 5468.99 | % Traded 0.83 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Lab | 5,700.00 | - | 68,152.05 | 28.87 | 5.69 | 18.06 | 1.70 | 2,216 | 12,964 | 0.09 |
| Sun Pharma | 1,779.70 | 0.13 | 427,009.64 | 40.87 | 5.91 | 15.13 | -0.02 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,373.00 | -1.38 | 169,183.13 | 68.08 | 11.30 | 14.63 | 6.62 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,686.50 | -0.94 | 124,767.91 | 58.30 | 16.63 | 25.17 | 18.84 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,511.80 | -1.14 | 122,118.85 | 22.44 | 3.91 | 16.90 | 3.16 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
